<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Antiphospholipid syndrome - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Antiphospholipid_syndrome" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Antiphospholipid_syndrome" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Antiphospholipid_syndrome" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Antiphospholipid_syndrome","wgTitle":"Antiphospholipid syndrome","wgCurRevisionId":670102164,"wgRevisionId":670102164,"wgArticleId":238273,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from October 2011","Articles with unsourced statements from January 2008","Articles that use a Medicine navs subtemplate","Coagulopathies","Rheumatology","Autoimmune diseases","Neurological disorders","Obstetrics","Syndromes"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Antiphospholipid_syndrome","wgRelevantArticleId":238273,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/7/78/Thrombotic_microangiopathy_-_very_high_mag.jpg/100px-Thrombotic_microangiopathy_-_very_high_mag.jpg","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q582207"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Antiphospholipid_syndrome skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Antiphospholipid syndrome</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Antiphospholipid syndrome</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Thrombotic_microangiopathy_-_very_high_mag.jpg" class="image"><img alt="Thrombotic microangiopathy - very high mag.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/78/Thrombotic_microangiopathy_-_very_high_mag.jpg/230px-Thrombotic_microangiopathy_-_very_high_mag.jpg" width="230" height="153" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/78/Thrombotic_microangiopathy_-_very_high_mag.jpg/345px-Thrombotic_microangiopathy_-_very_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/78/Thrombotic_microangiopathy_-_very_high_mag.jpg/460px-Thrombotic_microangiopathy_-_very_high_mag.jpg 2x" data-file-width="4272" data-file-height="2848" /></a>
<div><a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> showing an advanced <a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">thrombotic microangiopathy</a>, as may be seen in ALPA syndrome. <a href="/wiki/Kidney_biopsy" title="Kidney biopsy" class="mw-redirect">Kidney biopsy</a>. <a href="/wiki/PAS_stain" title="PAS stain" class="mw-redirect">PAS stain</a>.</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Rheumatology" title="Rheumatology">Rheumatology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/D68.6">D68.6</a> (<a href="/wiki/ILDS" title="ILDS" class="mw-redirect">ILDS</a> D68.810)</td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td>ICD9 289.81</td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/107320">107320</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb775.htm">775</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic2923.htm">med/2923</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a rel="nofollow" class="external text" href="http://patient.info/doctor/Antiphospholipid-syndrome">Antiphospholipid syndrome</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D016736">D016736</a></td>
</tr>
</table>
<p><b>Antiphospholipid syndrome</b> or <b>antiphospholipid antibody syndrome (APS or APLS),</b> or often also <b>Hughes syndrome</b>, is an <a href="/wiki/Autoimmune" title="Autoimmune" class="mw-redirect">autoimmune</a>, <a href="/wiki/Coagulation" title="Coagulation">hypercoagulable</a> state caused by antiphospholipid <a href="/wiki/Antibody" title="Antibody">antibodies</a>. APS provokes blood clots (<a href="/wiki/Thrombosis" title="Thrombosis">thrombosis</a>) in both <a href="/wiki/Artery" title="Artery">arteries</a> and <a href="/wiki/Vein" title="Vein">veins</a> as well as pregnancy-related complications such as <a href="/wiki/Miscarriage" title="Miscarriage">miscarriage</a>, <a href="/wiki/Stillbirth" title="Stillbirth">stillbirth</a>, <a href="/wiki/Premature_birth" title="Premature birth" class="mw-redirect">preterm delivery</a>, and severe <a href="/wiki/Preeclampsia" title="Preeclampsia" class="mw-redirect">preeclampsia</a>.</p>
<p>The diagnostic criteria require one clinical event, i.e. thrombosis or pregnancy complication, and two antibody <a href="/wiki/Blood_test" title="Blood test">blood tests</a> spaced at least three months apart that confirm the presence of either <a href="/wiki/Lupus_anticoagulant" title="Lupus anticoagulant">lupus anticoagulant</a>, or <a href="/wiki/Anti-apolipoprotein_antibodies" title="Anti-apolipoprotein antibodies">anti-β<sub>2</sub>-glycoprotein-I</a> (since β<sub>2</sub>-glycoprotein-I antibodies are a subset of anti-cardiolipin antibodies, an <a href="/wiki/Anti-cardiolipin_antibodies" title="Anti-cardiolipin antibodies">anti-cardiolipin</a> assay can be performed as a less specific proxy)<sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Antiphospholipid syndrome can be primary or secondary. Primary antiphospholipid syndrome occurs in the absence of any other related disease. Secondary antiphospholipid syndrome occurs with other autoimmune diseases, such as <a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a> (SLE). In rare cases, APS leads to rapid organ failure due to generalised thrombosis; this is termed "<a href="/wiki/Catastrophic_antiphospholipid_syndrome" title="Catastrophic antiphospholipid syndrome">catastrophic antiphospholipid syndrome</a>" (CAPS) and is associated with a high risk of death.</p>
<p>Antiphospholipid syndrome often requires treatment with <a href="/wiki/Anticoagulant" title="Anticoagulant">anticoagulant</a> medication such as <a href="/wiki/Heparin" title="Heparin">heparin</a> to reduce the risk of further episodes of thrombosis and improve the prognosis of pregnancy. <a href="/wiki/Warfarin" title="Warfarin">Warfarin</a>/<a href="/wiki/Coumadin" title="Coumadin" class="mw-redirect">Coumadin</a> is not used during pregnancy because it can cross the <a href="/wiki/Placenta" title="Placenta">placenta</a>, unlike heparin, and is <a href="/wiki/Teratogen" title="Teratogen" class="mw-redirect">teratogenic</a>.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Risk_factors"><span class="tocnumber">2</span> <span class="toctext">Risk factors</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Pathogenesis"><span class="tocnumber">3</span> <span class="toctext">Pathogenesis</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-5"><a href="#Lupus_anticoagulant"><span class="tocnumber">4.1</span> <span class="toctext">Lupus anticoagulant</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Anticardiolipin_antibodies"><span class="tocnumber">4.2</span> <span class="toctext">Anticardiolipin antibodies</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Criteria"><span class="tocnumber">4.3</span> <span class="toctext">Criteria</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#History"><span class="tocnumber">7</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-11"><a href="#Research"><span class="tocnumber">8</span> <span class="toctext">Research</span></a></li>
<li class="toclevel-1 tocsection-12"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Bibliography"><span class="tocnumber">10</span> <span class="toctext">Bibliography</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The presence of antiphospholipid antibodies (aPL) in the absence of blood clots or pregnancy-related complications does not indicate APS (see below for the diagnosis of APS).</p>
<p>Antiphospholipid syndrome can cause <a href="/wiki/Artery" title="Artery">arterial</a> or <a href="/wiki/Vein" title="Vein">venous</a> <a href="/wiki/Blood_clot" title="Blood clot" class="mw-redirect">blood clots</a>, in any organ system, or <a href="/wiki/Pregnancy" title="Pregnancy">pregnancy</a>-related complications. In APS patients, the most common venous event is <a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">deep vein thrombosis</a> of the lower extremities, and the most common arterial event is <a href="/wiki/Stroke" title="Stroke">stroke</a>. In pregnant women affected by APS, there is an increased risk of <a href="/wiki/Recurrent_miscarriage" title="Recurrent miscarriage">recurrent miscarriage</a>, <a href="/wiki/Intrauterine_growth_restriction" title="Intrauterine growth restriction">intrauterine growth restriction</a>, and <a href="/wiki/Preterm_birth" title="Preterm birth">preterm birth</a>.<sup id="cite_ref-TongViall2014_2-0" class="reference"><a href="#cite_note-TongViall2014-2"><span>[</span>2<span>]</span></a></sup> A frequent cause of such complications is <a href="/wiki/Placental_infarction" title="Placental infarction">placental infarctions</a>. In some cases, APS seems to be the leading cause of mental and/or development retardation in the newborn, due to an aPL-induced inhibition of <a href="/wiki/Trophoblast" title="Trophoblast">trophoblast</a> differentiation. The antiphospholipid syndrome responsible for most of the miscarriages in later trimesters seen in concomitant <a href="/wiki/Systemic_lupus_erythematosus_and_pregnancy" title="Systemic lupus erythematosus and pregnancy">systemic lupus erythematosus and pregnancy</a>.<sup id="cite_ref-hopkins_3-0" class="reference"><a href="#cite_note-hopkins-3"><span>[</span>3<span>]</span></a></sup></p>
<p>Other common findings, although not part of the APS classification criteria, are <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">low platelet count</a>, <a href="/wiki/Valvular_heart_disease" title="Valvular heart disease">heart valve disease</a>, and <a href="/wiki/Livedo_reticularis" title="Livedo reticularis">livedo reticularis</a>. There are also associations between antiphospholipid antibodies and <a href="/wiki/Headache" title="Headache">headaches</a>, <a href="/wiki/Migraine" title="Migraine">migraines</a>, and <a href="/wiki/Oscillopsia" title="Oscillopsia">oscillopsia</a>.<sup id="cite_ref-pmid9669481_4-0" class="reference"><a href="#cite_note-pmid9669481-4"><span>[</span>4<span>]</span></a></sup> Some studies have shown the presence of antiphospholipid antibodies in the blood and spinal fluid of patients with psychological symptoms.<sup id="cite_ref-pmid17868908_5-0" class="reference"><a href="#cite_note-pmid17868908-5"><span>[</span>5<span>]</span></a></sup></p>
<p>Very few patients with primary APS go on to develop <a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">SLE</a>.</p>
<h2><span class="mw-headline" id="Risk_factors">Risk factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=2" title="Edit section: Risk factors">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Risk factors for developing antiphospholipid syndrome include:<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2011)">citation needed</span></a></i>]</sup></p>
<ul>
<li>Primary APS
<ul>
<li><a href="/wiki/Genetic_marker" title="Genetic marker">genetic marker</a> <a href="/wiki/HLA-DR7" title="HLA-DR7">HLA-DR7</a></li>
</ul>
</li>
<li>Secondary APS
<ul>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">SLE</a> or other autoimmune disorders</li>
<li><a href="/wiki/Genetic_markers" title="Genetic markers" class="mw-redirect">Genetic markers</a>: <a href="/wiki/HLA-B8" title="HLA-B8">HLA-B8</a>, <a href="/wiki/HLA-DR2" title="HLA-DR2">HLA-DR2</a>, <a href="/wiki/HLA-DR3" title="HLA-DR3">HLA-DR3</a></li>
<li><a href="/wiki/Race_(classification_of_humans)" title="Race (classification of humans)" class="mw-redirect">Race</a>: <a href="/wiki/Black_people" title="Black people">Blacks</a>, <a href="/wiki/Hispanics" title="Hispanics" class="mw-redirect">Hispanics</a>, <a href="/wiki/Asians" title="Asians" class="mw-redirect">Asians</a>, and <a href="/wiki/Indigenous_peoples_of_the_Americas" title="Indigenous peoples of the Americas">Native Americans</a></li>
</ul>
</li>
</ul>
<h2><span class="mw-headline" id="Pathogenesis">Pathogenesis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=3" title="Edit section: Pathogenesis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Antiphospholipid syndrome is an <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune disease</a>, in which "antiphospholipid antibodies" (anticardiolipin antibodies and lupus anticoagulant) react against proteins that bind to anionic <a href="/wiki/Phospholipid" title="Phospholipid">phospholipids</a> on <a href="/wiki/Plasma_membrane" title="Plasma membrane" class="mw-redirect">plasma membranes</a>. Like many <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a>, it is more common in women than in men. The exact <a href="/wiki/Etiology" title="Etiology">cause</a> is not known, but activation of the system of coagulation is evident. Clinically important antiphospholipid antibodies (those that arise as a result of the autoimmune process) are associated with thrombosis and vascular disease. The syndrome can be divided into primary (no underlying disease state) and secondary (in association with an underlying disease state) forms.</p>
<p>Anti-ApoH and a subset of anti-cardiolipin antibodies bind to ApoH, which in turn inhibits <a href="/wiki/Protein_C" title="Protein C">Protein C</a>, a <a href="/wiki/Glycoprotein" title="Glycoprotein">glycoprotein</a> with regulatory function upon the common pathway of coagulation (by degradating activated <a href="/wiki/Factor_V" title="Factor V">factor V</a>).</p>
<p><a href="/wiki/Lupus_anticoagulant" title="Lupus anticoagulant">Lupus anticoagulant</a> (LAC) antibodies bind to <a href="/wiki/Prothrombin" title="Prothrombin" class="mw-redirect">prothrombin</a>, thus increasing its cleavage to <a href="/wiki/Thrombin" title="Thrombin">thrombin</a>, its active form.</p>
<p>In APS there are also antibodies binding to <a href="/wiki/Protein_S" title="Protein S">Protein S</a>, which is a co-factor of protein C. Thus, anti-protein S antibodies decrease protein C efficiency.<sup id="cite_ref-Triplett2002_6-0" class="reference"><a href="#cite_note-Triplett2002-6"><span>[</span>6<span>]</span></a></sup></p>
<p><a href="/wiki/Annexin_A5" title="Annexin A5">Annexin A5</a> forms a shield around negatively charged phospholipid molecules, thus reducing their availability for coagulation. Thus, anti-annexin A5 antibodies increase phospholipid-dependent coagulation steps.<sup id="cite_ref-Rand1998_7-0" class="reference"><a href="#cite_note-Rand1998-7"><span>[</span>7<span>]</span></a></sup></p>
<p>The <a href="/wiki/Lupus_anticoagulant" title="Lupus anticoagulant">Lupus anticoagulant</a> antibodies are those that show the closest association with thrombosis, those that target β<sub>2</sub>glycoprotein 1 have a greater association with thrombosis than those that target prothrombin. Anticardiolipin antibodies are associated with thrombosis at moderate to high titres (&gt;40 GPLU or MPLU). Patients with both Lupus anticoagulant antibodies and moderate/high titre anticardiolipin antibodies show a greater risk of thrombosis than with one alone.</p>
<p>The increased risks of <a href="/wiki/Recurrent_miscarriage" title="Recurrent miscarriage">recurrent miscarriage</a>, <a href="/wiki/Intrauterine_growth_restriction" title="Intrauterine growth restriction">intrauterine growth restriction</a> and <a href="/wiki/Preterm_birth" title="Preterm birth">preterm birth</a> by antiphospholipid antibodies, as supported by <i><a href="/wiki/In_vitro" title="In vitro">in vitro</a></i> studies, include decreased <a href="/wiki/Trophoblast" title="Trophoblast">trophoblast</a> viability, syncytialization and invasion, deranged production of hormones and signalling molecules by trophoblasts, as well as activation of <a href="/wiki/Coagulation" title="Coagulation">coagulation</a> and <a href="/wiki/Complement_system" title="Complement system">complement pathways</a>.<sup id="cite_ref-TongViall2014_2-1" class="reference"><a href="#cite_note-TongViall2014-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=4" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Antiphospholipid syndrome is tested for in the <a href="/wiki/Laboratory" title="Laboratory">laboratory</a> using both liquid phase coagulation assays (<a href="/wiki/Lupus_anticoagulant" title="Lupus anticoagulant">lupus anticoagulant</a>) and solid phase <a href="/wiki/ELISA" title="ELISA">ELISA</a> assays (<a href="/wiki/Anti-cardiolipin_antibodies" title="Anti-cardiolipin antibodies">anti-cardiolipin antibodies</a>).</p>
<p>Genetic thrombophilia is part of the differential diagnosis of APS and can coexist in some APS patients. Presence of genetic thrombophilia may determine the need for anticoagulation therapy. Thus genetic thrombophilia screening can consist of:</p>
<ul>
<li>Further studies for <a href="/wiki/Factor_V_Leiden" title="Factor V Leiden">Factor V Leiden</a> variant and the <a href="/wiki/Prothrombin_G20210A" title="Prothrombin G20210A">prothrombin G20210A mutation</a>, <a href="/wiki/Factor_VIII" title="Factor VIII">Factor VIII</a> levels, <a href="/wiki/MTHFR" title="MTHFR" class="mw-redirect">MTHFR</a> mutation.</li>
<li>Levels of <a href="/wiki/Protein_C" title="Protein C">protein C</a>, free and total <a href="/wiki/Protein_S" title="Protein S">protein S</a>, <a href="/wiki/Factor_VIII" title="Factor VIII">Factor VIII</a>, <a href="/wiki/Antithrombin" title="Antithrombin">antithrombin</a>, <a href="/wiki/Plasminogen" title="Plasminogen" class="mw-redirect">plasminogen</a>, <a href="/wiki/Tissue_plasminogen_activator" title="Tissue plasminogen activator">tissue plasminogen activator</a> (TPA) and <a href="/wiki/Plasminogen_activator_inhibitor-1" title="Plasminogen activator inhibitor-1">plasminogen activator inhibitor-1</a> (PAI-1)</li>
</ul>
<p>The testing of antibodies to the possible individual targets of aPL such as <a href="/wiki/Apolipoprotein_H" title="Apolipoprotein H">β<sub>2</sub> glycoprotein 1</a> and <a href="/w/index.php?title=Antiphosphatidyl_serine&amp;action=edit&amp;redlink=1" class="new" title="Antiphosphatidyl serine (page does not exist)">antiphosphatidyl serine</a> is currently under debate as testing for anticardiolipin appears to be currently sensitive and specific for diagnosis of APS even though <a href="/wiki/Cardiolipin" title="Cardiolipin">cardiolipin</a> is not considered an <a href="/wiki/In_vivo" title="In vivo">in vivo</a> target for antiphospholipid antibodies.</p>
<h3><span class="mw-headline" id="Lupus_anticoagulant">Lupus anticoagulant</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=5" title="Edit section: Lupus anticoagulant">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>This is tested for by using a minimum of two coagulation tests that are phospholipid sensitive, due to the heterogeneous nature of the <a href="/wiki/Lupus_anticoagulant" title="Lupus anticoagulant">lupus anticoagulant</a> antibodies. The patient on initial screening will typically have been found to have a prolonged <a href="/wiki/APTT" title="APTT" class="mw-redirect">APTT</a> that does not correct in an 80:20 mixture with normal human <a href="/wiki/Blood_plasma" title="Blood plasma">plasma</a> (50:50 mixes with normal plasma are insensitive to all but the highest antibody levels). The APTT (plus 80:20 mix), <a href="/wiki/Dilute_Russell%27s_viper_venom_time" title="Dilute Russell's viper venom time">dilute Russell's viper venom time</a> (DRVVT), the <a href="/wiki/Kaolin_clotting_time" title="Kaolin clotting time">kaolin clotting time</a> (KCT), <a href="/w/index.php?title=Dilute_thromboplastin_time&amp;action=edit&amp;redlink=1" class="new" title="Dilute thromboplastin time (page does not exist)">dilute thromboplastin time</a> (TDT/DTT) or <a href="/wiki/Prothrombin_time" title="Prothrombin time">prothrombin time</a> (using a lupus sensitive <a href="/wiki/Thromboplastin" title="Thromboplastin">thromboplastin</a>) are the principal tests used for the detection of <a href="/wiki/Lupus_anticoagulant" title="Lupus anticoagulant">lupus anticoagulant</a>. These tests must be carried out on a minimum of two occasions at least 6 weeks apart and be positive on each occasion demonstrating persistent positivity to allow a diagnosis of antiphospholipid syndrome. This is to prevent patients with transient positive tests (due to infection etc.) being diagnosed as positive.</p>
<p>Distinguishing a lupus antibody from a specific coagulation factor inhibitor (e.g.: <a href="/wiki/Factor_VIII" title="Factor VIII">Factor VIII</a>). This is normally achieved by differentiating the effects of a lupus anticoagulant on factor assays from the effects of a specific coagulation factor antibody. The lupus anticoagulant will inhibit all the contact activation pathway factors (<a href="/wiki/Factor_VIII" title="Factor VIII">Factor VIII</a>, <a href="/wiki/Factor_IX" title="Factor IX">Factor IX</a>, <a href="/wiki/Factor_XI" title="Factor XI">Factor XI</a> and <a href="/wiki/Factor_XII" title="Factor XII">Factor XII</a>). Lupus anticoagulant will also rarely cause a factor assay to give a result lower than 35 iu/dl (35%) whereas a specific factor antibody will rarely give a result higher than 10 iu/dl (10%). Monitoring IV anticoagulant therapy by the <a href="/wiki/Partial_thromboplastin_time" title="Partial thromboplastin time">APTT ratio</a> is compromised due to the effects of the lupus anticoagulant and in these situations is generally best performed using a chromogenic assay based on the inhibition of <a href="/wiki/Factor_Xa" title="Factor Xa" class="mw-redirect">Factor Xa</a> by <a href="/wiki/Antithrombin" title="Antithrombin">antithrombin</a> in the presence of <a href="/wiki/Heparin" title="Heparin">heparin</a>.</p>
<h3><span class="mw-headline" id="Anticardiolipin_antibodies">Anticardiolipin antibodies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=6" title="Edit section: Anticardiolipin antibodies">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>These can be detected using an <a href="/wiki/ELISA" title="ELISA">enzyme-linked immunosorbent assay</a> (ELISA) <a href="/wiki/Immunology" title="Immunology">immunological test</a>, which screens for the presence of β<sub>2</sub>glycoprotein 1 dependent anticardiolipin antibodies (ACA).</p>
<p>A <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">low platelet count</a> and positivity for antibodies against β<sub>2</sub>-glycoprotein 1 or <a href="/wiki/Phosphatidylserine" title="Phosphatidylserine">phosphatidylserine</a> may also be observed in a positive diagnosis.</p>
<h3><span class="mw-headline" id="Criteria">Criteria</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=7" title="Edit section: Criteria">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Classification with APS requires evidence of both one or more specific, documented clinical events (either a vascular thrombosis and/or adverse obstetric event) and the confirmed presence of a repeated aPL. The Sapporo APS classification criteria (1998, published in 1999) were replaced by the Sydney criteria in 2006.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup> Based on the most recent criteria, classification with APS requires one clinical and one laboratory manifestation:</p>
<ul>
<li>Clinical:
<ul>
<li>A documented episode of arterial, venous, or small vessel thrombosis — other than superficial venous thrombosis — in any tissue or organ by objective validated criteria with no significant evidence of inflammation in the vessel wall, and/or</li>
<li>1 or more unexplained deaths of a morphologically normal fetus (documented by ultrasound or direct examination of the fetus) at or beyond the 10th week of gestation and/or 3 or more unexplained consecutive spontaneous abortions before the 10th week of gestation, with maternal anatomic or hormonal abnormalities and paternal and maternal chromosomal causes excluded or at least 1 premature birth of a morphologically normal neonate before the 34th week of gestation due to eclampsia or severe pre-eclampsia according to standard definitions, or recognized features of placental insufficiency <i>plus</i></li>
</ul>
</li>
<li>Laboratory:
<ul>
<li>Anti-cardiolipin IgG and/or IgM measured by standardized, non-cofactor dependent ELISA on 2 or more occasions, not less than 12 weeks apart; medium or high titre (i.e., &gt; 40 GPL or MPL, or &gt; the 99th percentile) and/or</li>
<li>Anti-β2 glycoprotein I IgG and/or IgM measured by standardized ELISA on 2 or more occasions, not less than 12 weeks apart; medium or high titre (&gt; the 99th percentile) and/or</li>
<li>Lupus anticoagulant detected on 2 occasions not less than 12 weeks apart according to the guidelines of the International Society of Thrombosis and Hemostasis.</li>
</ul>
</li>
</ul>
<p>There are 3 distinct APS disease entities: primary (the absence of any comorbidity), secondary (when there is a pre-existing autoimmune condition, most frequently systemic lupus erythematosus, SLE), and catastrophic (when there is simultaneous multi-organ failure with small vessel occlusion).</p>
<p>According to a 2006 consensus statement,<sup id="cite_ref-pmid16420554_9-0" class="reference"><a href="#cite_note-pmid16420554-9"><span>[</span>9<span>]</span></a></sup> it is advisable to classify APS into one of the following categories for research purposes:</p>
<ul>
<li>I: more than one laboratory criterion present in any combination;</li>
<li>IIa: lupus anticoagulant present alone</li>
<li>IIb: anti-cardiolipin IgG and/or IgM present alone in medium or high titers</li>
<li>IIc: anti-β2 glycoprotein I IgG and/or IgM present alone in a titer greater than 99th percentile</li>
</ul>
<p>The International Consensus Statement is commonly used for Catastrophic APS diagnosis.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> Based on this statement, Definite CAPS diagnosis requires:</p>
<ul>
<li>a) Vascular thrombosis in three or more organs or tissues <b>and</b></li>
<li>b) Development of manifestations simultaneously or in less than a week <b>and</b></li>
<li>c) Evidence of small vessel thrombosis in at least one organ or tissue <b>and</b></li>
<li>d) Laboratory confirmation of the presence of aPL.</li>
</ul>
<p>VDRL, which detects antibodies against syphilis, may have a false positive result in aPL-positive patients (aPL bind to the lipids in the test and make it come out positive), although the more specific test for syphilis, FTA-Abs, that use recombinant antigens will not have a false-positive result.</p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=8" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Often, this disease is treated by giving <a href="/wiki/Aspirin" title="Aspirin">aspirin</a> to inhibit platelet activation, and/or <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> as an <a href="/wiki/Anticoagulant" title="Anticoagulant">anticoagulant</a>. The goal of the <a href="/wiki/Prophylaxis" title="Prophylaxis" class="mw-redirect">prophylactic</a> treatment with warfarin is to maintain the patient's <a href="/wiki/Prothrombin_time" title="Prothrombin time">INR</a> between 2.0 and 3.0.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup> It is not usually done in patients who have had no thrombotic symptoms.</p>
<p>Anticoagulation appears to prevent <a href="/wiki/Miscarriage" title="Miscarriage">miscarriage</a> in pregnant women.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> In pregnancy, <a href="/wiki/Low_molecular_weight_heparin" title="Low molecular weight heparin">low molecular weight heparin</a> and low-dose <a href="/wiki/Aspirin" title="Aspirin">aspirin</a> are used instead of warfarin because of warfarin's <a href="/wiki/Teratogen" title="Teratogen" class="mw-redirect">teratogenicity</a>. Women with recurrent miscarriage are often advised to take aspirin and to start low molecular weight heparin treatment after missing a <a href="/wiki/Menstrual_cycle" title="Menstrual cycle">menstrual cycle</a>. In refractory cases <a href="/wiki/Plasmapheresis" title="Plasmapheresis">plasmapheresis</a> may be used.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2008)">citation needed</span></a></i>]</sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=9" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The long-term prognosis for APS is determined mainly by recurrent <a href="/wiki/Thrombosis" title="Thrombosis">thrombosis</a>, which may occur in up to 29% of patients, sometimes despite antithrombotic therapy.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2011)">citation needed</span></a></i>]</sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=10" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Antiphospholipid syndrome was described in full in the 1980s, after various previous reports of specific antibodies in people with systemic lupus erythematosus and thrombosis.<sup id="cite_ref-Antiphospholipid_13-0" class="reference"><a href="#cite_note-Antiphospholipid-13"><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-Hughes_14-0" class="reference"><a href="#cite_note-Hughes-14"><span>[</span>14<span>]</span></a></sup> The syndrome is sometimes <a href="/wiki/Eponym" title="Eponym">referred to</a> as "Hughes syndrome", after the <a href="/wiki/Rheumatology" title="Rheumatology">rheumatologist</a> Graham R.V. Hughes (<a href="/wiki/St._Thomas%27_Hospital" title="St. Thomas' Hospital" class="mw-redirect">St. Thomas' Hospital</a>, <a href="/wiki/London" title="London">London</a>, <a href="/wiki/United_Kingdom" title="United Kingdom">UK</a>) who worked at the Louise Coote Lupus Unit at <a href="/wiki/St_Thomas%27_Hospital" title="St Thomas' Hospital">St Thomas' Hospital</a> in London and at the London Lupus Centre at London Bridge Hospital, playing a central role in the description of the condition.<sup id="cite_ref-Hughes_14-1" class="reference"><a href="#cite_note-Hughes-14"><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=11" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>APS ACTION (the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking), is the first-ever international research network that has been created to design and conduct large-scale, multicenter clinical trials in persistently antiphospholipid antibody (aPL) positive patients.<sup id="cite_ref-pmid21303838_16-0" class="reference"><a href="#cite_note-pmid21303838-16"><span>[</span>16<span>]</span></a></sup> The network consists of a multidisciplinary group of physicians and investigators from around the world who are interested in antiphospholipid syndrome (APS) research. The primary mission of APS ACTION is to prevent, treat, and cure antiphospholipid antibody (aPL) associated clinical manifestations through high quality, multicenter, and multidisciplinary clinical research.</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=12" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 35em; -webkit-column-width: 35em; column-width: 35em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.apsaction.org/about.html">"Aps | Action"</a>. Apsaction.org<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-11-06</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.btitle=Aps+%26%23124%3B+Action&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.apsaction.org%2Fabout.html&amp;rft.pub=Apsaction.org&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-TongViall2014-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-TongViall2014_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-TongViall2014_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Tong, M.; Viall, C. A.; Chamley, L. W. (2014). "Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment". <i>Human Reproduction Update</i> <b>21</b> (1): 97–118. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhumupd%2Fdmu049">10.1093/humupd/dmu049</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1355-4786">1355-4786</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Antiphospholipid+antibodies+and+the+placenta%3A+a+systematic+review+of+their+in+vitro+effects+and+modulation+by+treatment&amp;rft.au=Chamley%2C+L.+W.&amp;rft.aufirst=M.&amp;rft.aulast=Tong&amp;rft.au=Tong%2C+M.&amp;rft.au=Viall%2C+C.+A.&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhumupd%2Fdmu049&amp;rft.issn=1355-4786&amp;rft.issue=1&amp;rft.jtitle=Human+Reproduction+Update&amp;rft.pages=97-118&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-hopkins-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-hopkins_3-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.hopkinslupus.org/lupus-info/lifestyle-additional-information/lupus-pregnancy/">Lupus and Pregnancy</a> by Michelle Petri. The Johns Hopkins Lupus Center. Retrieved May 2011</span></li>
<li id="cite_note-pmid9669481-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9669481_4-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rinne T, Bronstein AM, Rudge P, Gresty MA, Luxon LM (1998). "Bilateral loss of vestibular function: clinical findings in 53 patients". <i>J. Neurol.</i> <b>245</b> (6–7): 314–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs004150050225">10.1007/s004150050225</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9669481">9669481</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Bilateral+loss+of+vestibular+function%3A+clinical+findings+in+53+patients&amp;rft.aulast=Rinne+T%2C+Bronstein+AM%2C+Rudge+P%2C+Gresty+MA%2C+Luxon+LM&amp;rft.au=Rinne+T%2C+Bronstein+AM%2C+Rudge+P%2C+Gresty+MA%2C+Luxon+LM&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs004150050225&amp;rft_id=info%3Apmid%2F9669481&amp;rft.issue=6%E2%80%937&amp;rft.jtitle=J.+Neurol.&amp;rft.pages=314-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=245" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17868908-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17868908_5-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sokol DK, O'Brien RS, Wagenknecht DR, Rao T, McIntyre JA (2007). "Antiphospholipid antibodies in blood and cerebrospinal fluid of patients with psychosis". <i>Journal of Neuroimmunology</i> <b>190</b> (1): 151–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jneuroim.2007.08.002">10.1016/j.jneuroim.2007.08.002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17868908">17868908</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Antiphospholipid+antibodies+in+blood+and+cerebrospinal+fluid+of+patients+with+psychosis&amp;rft.aulast=Sokol+DK%2C+O%27Brien+RS%2C+Wagenknecht+DR%2C+Rao+T%2C+McIntyre+JA&amp;rft.au=Sokol+DK%2C+O%27Brien+RS%2C+Wagenknecht+DR%2C+Rao+T%2C+McIntyre+JA&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jneuroim.2007.08.002&amp;rft_id=info%3Apmid%2F17868908&amp;rft.issue=1&amp;rft.jtitle=Journal+of+Neuroimmunology&amp;rft.pages=151-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=190" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Triplett2002-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-Triplett2002_6-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Triplett DA (November 2002). "Antiphospholipid antibodies.". <i>Archives of pathology &amp; laboratory medicine</i> <b>126</b> (11): 1424–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1043%2F0003-9985%282002%291261424%3AAA2.0.CO%3B2">10.1043/0003-9985(2002)1261424:AA2.0.CO;2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12421152">12421152</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Antiphospholipid+antibodies.&amp;rft.aulast=Triplett+DA&amp;rft.au=Triplett+DA&amp;rft.date=November+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1043%2F0003-9985%282002%291261424%3AAA2.0.CO%3B2&amp;rft_id=info%3Apmid%2F12421152&amp;rft.issue=11&amp;rft.jtitle=Archives+of+pathology+%26+laboratory+medicine&amp;rft.pages=1424-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=126" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rand1998-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rand1998_7-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rand JH (1998). "Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms.". <i>The American journal of the medical sciences</i> <b>316</b> (2): 142–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00000441-199808000-00009">10.1097/00000441-199808000-00009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9704667">9704667</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Antiphospholipid+antibody+syndrome%3A+new+insights+on+thrombogenic+mechanisms.&amp;rft.aulast=Rand+JH&amp;rft.au=Rand+JH&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00000441-199808000-00009&amp;rft_id=info%3Apmid%2F9704667&amp;rft.issue=2&amp;rft.jtitle=The+American+journal+of+the+medical+sciences&amp;rft.pages=142-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=316" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation journal">Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (February 2006). "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)". <i>J. Thromb. Haemost.</i> <b>4</b> (2): 295–306. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1538-7836.2006.01753.x">10.1111/j.1538-7836.2006.01753.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16420554">16420554</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=International+consensus+statement+on+an+update+of+the+classification+criteria+for+definite+antiphospholipid+syndrome+%28APS%29&amp;rft.aulast=Miyakis+S%2C+Lockshin+MD%2C+Atsumi+T%2C+Branch+DW%2C+Brey+RL%2C+Cervera+R%2C+Derksen+RH%2C+DE+Groot+PG%2C+Koike+T%2C+Meroni+PL%2C+Reber+G%2C+Shoenfeld+Y%2C+Tincani+A%2C+Vlachoyiannopoulos+PG%2C+Krilis+SA&amp;rft.au=Miyakis+S%2C+Lockshin+MD%2C+Atsumi+T%2C+Branch+DW%2C+Brey+RL%2C+Cervera+R%2C+Derksen+RH%2C+DE+Groot+PG%2C+Koike+T%2C+Meroni+PL%2C+Reber+G%2C+Shoenfeld+Y%2C+Tincani+A%2C+Vlachoyiannopoulos+PG%2C+Krilis+SA&amp;rft.date=February+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1538-7836.2006.01753.x&amp;rft_id=info%3Apmid%2F16420554&amp;rft.issue=2&amp;rft.jtitle=J.+Thromb.+Haemost.&amp;rft.pages=295-306&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16420554-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16420554_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (February 2006). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2006.01753.x/full">"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)"</a>. <i>J. Thromb. Haemost.</i> <b>4</b> (2): 295–306. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1538-7836.2006.01753.x">10.1111/j.1538-7836.2006.01753.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16420554">16420554</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=International+consensus+statement+on+an+update+of+the+classification+criteria+for+definite+antiphospholipid+syndrome+%28APS%29&amp;rft.aulast=Miyakis+S%2C+Lockshin+MD%2C+Atsumi+T%2C+Branch+DW%2C+Brey+RL%2C+Cervera+R%2C+Derksen+RH%2C+DE+Groot+PG%2C+Koike+T%2C+Meroni+PL%2C+Reber+G%2C+Shoenfeld+Y%2C+Tincani+A%2C+Vlachoyiannopoulos+PG%2C+Krilis+SA&amp;rft.au=Miyakis+S%2C+Lockshin+MD%2C+Atsumi+T%2C+Branch+DW%2C+Brey+RL%2C+Cervera+R%2C+Derksen+RH%2C+DE+Groot+PG%2C+Koike+T%2C+Meroni+PL%2C+Reber+G%2C+Shoenfeld+Y%2C+Tincani+A%2C+Vlachoyiannopoulos+PG%2C+Krilis+SA&amp;rft.date=February+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fj.1538-7836.2006.01753.x%2Ffull&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1538-7836.2006.01753.x&amp;rft_id=info%3Apmid%2F16420554&amp;rft.issue=2&amp;rft.jtitle=J.+Thromb.+Haemost.&amp;rft.pages=295-306&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA, Shoenfeld Y (2003). "Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines". <i>Lupus</i> <b>12</b> (7): 530–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1191%2F0961203303lu394oa">10.1191/0961203303lu394oa</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12892393">12892393</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Catastrophic+antiphospholipid+syndrome%3A+international+consensus+statement+on+classification+criteria+and+treatment+guidelines&amp;rft.au=Asherson+RA%2C+Cervera+R%2C+de+Groot+PG%2C+Erkan+D%2C+Boffa+MC%2C+Piette+JC%2C+Khamashta+MA%2C+Shoenfeld+Y&amp;rft.aulast=Asherson+RA%2C+Cervera+R%2C+de+Groot+PG%2C+Erkan+D%2C+Boffa+MC%2C+Piette+JC%2C+Khamashta+MA%2C+Shoenfeld+Y&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1191%2F0961203303lu394oa&amp;rft_id=info%3Apmid%2F12892393&amp;rft.issue=7&amp;rft.jtitle=Lupus&amp;rft.pages=530-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Horton JD, Bushwick BM (1999). "Warfarin therapy: evolving strategies in anticoagulation". <i>American Family Physician</i> <b>59</b> (3): 635–46. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10029789">10029789</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Warfarin+therapy%3A+evolving+strategies+in+anticoagulation&amp;rft.au=Horton+JD%2C+Bushwick+BM&amp;rft.aulast=Horton+JD%2C+Bushwick+BM&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F10029789&amp;rft.issue=3&amp;rft.jtitle=American+Family+Physician&amp;rft.pages=635-46&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=59" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">de Jong PG, Goddijn M, Middeldorp S (2013). "Antithrombotic therapy for pregnancy loss". <i>Human Reproduction Update</i> <b>19</b> (6): 656–673. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhumupd%2Fdmt019">10.1093/humupd/dmt019</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23766357">23766357</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Antithrombotic+therapy+for+pregnancy+loss&amp;rft.au=de+Jong+PG%2C+Goddijn+M%2C+Middeldorp+S&amp;rft.aulast=de+Jong+PG%2C+Goddijn+M%2C+Middeldorp+S&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhumupd%2Fdmt019&amp;rft_id=info%3Apmid%2F23766357&amp;rft.issue=6&amp;rft.jtitle=Human+Reproduction+Update&amp;rft.pages=656-673&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Antiphospholipid-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-Antiphospholipid_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (October 2010). "Antiphospholipid syndrome". <i>Lancet</i> <b>376</b> (9751): 1498–509. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2810%2960709-X">10.1016/S0140-6736(10)60709-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20822807">20822807</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Antiphospholipid+syndrome&amp;rft.aulast=Ruiz-Irastorza+G%2C+Crowther+M%2C+Branch+W%2C+Khamashta+MA&amp;rft.au=Ruiz-Irastorza+G%2C+Crowther+M%2C+Branch+W%2C+Khamashta+MA&amp;rft.date=October+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2810%2960709-X&amp;rft_id=info%3Apmid%2F20822807&amp;rft.issue=9751&amp;rft.jtitle=Lancet&amp;rft.pages=1498-509&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=376" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hughes-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hughes_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hughes_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Hughes GR (October 1983). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1549319">"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant"</a>. <i>Br. Med. J. (Clin Res Ed)</i> <b>287</b> (6399): 1088–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.287.6399.1088">10.1136/bmj.287.6399.1088</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1549319">1549319</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6414579">6414579</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Thrombosis%2C+abortion%2C+cerebral+disease%2C+and+the+lupus+anticoagulant&amp;rft.au=Hughes+GR&amp;rft.aulast=Hughes+GR&amp;rft.date=October+1983&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1549319&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.287.6399.1088&amp;rft_id=info%3Apmc%2F1549319&amp;rft_id=info%3Apmid%2F6414579&amp;rft.issue=6399&amp;rft.jtitle=Br.+Med.+J.+%28Clin+Res+Ed%29&amp;rft.pages=1088-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=287" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Sanna G, D'Cruz D, Cuadrado MJ (August 2006). "Cerebral manifestations in the antiphospholipid (Hughes) syndrome". <i>Rheum. Dis. Clin. North Am.</i> <b>32</b> (3): 465–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.rdc.2006.05.010">10.1016/j.rdc.2006.05.010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16880079">16880079</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Cerebral+manifestations+in+the+antiphospholipid+%28Hughes%29+syndrome&amp;rft.aulast=Sanna+G%2C+D%27Cruz+D%2C+Cuadrado+MJ&amp;rft.au=Sanna+G%2C+D%27Cruz+D%2C+Cuadrado+MJ&amp;rft.date=August+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.rdc.2006.05.010&amp;rft_id=info%3Apmid%2F16880079&amp;rft.issue=3&amp;rft.jtitle=Rheum.+Dis.+Clin.+North+Am.&amp;rft.pages=465-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21303838-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21303838_16-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Erkan D, Derksen R, Levy R, Machin S, Ortel T, Pierangeli S, Roubey R, Lockshin M (2011). "Antiphospholipid Syndrome Clinical Research Task Force Report". <i>Lupus</i> <b>20</b> (2): 219–224. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1177%2F0961203310395053">10.1177/0961203310395053</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21303838">21303838</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.atitle=Antiphospholipid+Syndrome+Clinical+Research+Task+Force+Report&amp;rft.au=Erkan+D%2C+Derksen+R%2C+Levy+R%2C+Machin+S%2C+Ortel+T%2C+Pierangeli+S%2C+Roubey+R%2C+Lockshin+M&amp;rft.aulast=Erkan+D%2C+Derksen+R%2C+Levy+R%2C+Machin+S%2C+Ortel+T%2C+Pierangeli+S%2C+Roubey+R%2C+Lockshin+M&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1177%2F0961203310395053&amp;rft_id=info%3Apmid%2F21303838&amp;rft.issue=2&amp;rft.jtitle=Lupus&amp;rft.pages=219-224&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="Bibliography">Bibliography</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=13" title="Edit section: Bibliography">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><span class="citation book">Triona Holden (2003). <i>Positive Options for Antiphospholipid Syndrome (APS): Self-Help and Treatment</i>. Hunter House (CA). <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-89793-409-1" title="Special:BookSources/0-89793-409-1">0-89793-409-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.aulast=Triona+Holden&amp;rft.au=Triona+Holden&amp;rft.btitle=Positive+Options+for+Antiphospholipid+Syndrome+%28APS%29%3A+Self-Help+and+Treatment&amp;rft.date=2003&amp;rft.genre=book&amp;rft.isbn=0-89793-409-1&amp;rft.pub=Hunter+House+%28CA%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><span class="citation book">Kay Thackray (2003). <i>Sticky Blood Explained</i>. Braiswick. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-898030-77-4" title="Special:BookSources/1-898030-77-4">1-898030-77-4</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.au=Kay+Thackray&amp;rft.aulast=Kay+Thackray&amp;rft.btitle=Sticky+Blood+Explained&amp;rft.date=2003&amp;rft.genre=book&amp;rft.isbn=1-898030-77-4&amp;rft.pub=Braiswick&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> A personal account of dealing with the condition.</li>
<li><span class="citation book">Graham R V Hughes (2009). <i>Understanding Hughes Syndrome: Case Studies for Patients</i>. Springer. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-84800-375-7" title="Special:BookSources/1-84800-375-7">1-84800-375-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntiphospholipid+syndrome&amp;rft.au=Graham+R+V+Hughes&amp;rft.aulast=Graham+R+V+Hughes&amp;rft.btitle=Understanding+Hughes+Syndrome%3A+Case+Studies+for+Patients&amp;rft.date=2009&amp;rft.genre=book&amp;rft.isbn=1-84800-375-7&amp;rft.pub=Springer&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> 50 case studies to help you work out whether you have it.</li>
</ul>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit&amp;section=14" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.apsfa.org">APS Foundation of America, Inc.</a></li>
<li><a rel="nofollow" class="external text" href="http://www.hughes-syndrome.org">Hughes Syndrome Foundation</a></li>
<li><a rel="nofollow" class="external text" href="http://www.telegraph.co.uk/health/4400796/Hughes-Syndrome-simple-to-treat-but-all-too-often-ignored.html">Interview with Hughes</a> <a href="/wiki/The_Daily_Telegraph" title="The Daily Telegraph">The Daily Telegraph</a> February 2, 2009. Accessed February 3, 2009.</li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Autoantibodies" title="Template:Autoantibodies"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Autoantibodies" title="Template talk:Autoantibodies"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Autoantibodies&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Medical_test" title="Medical test">Medical test</a>: <a href="/wiki/Antibody" title="Antibody">Antibodies</a>: <a href="/wiki/Autoantibody" title="Autoantibody">autoantibodies</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Anti-nuclear_antibody" title="Anti-nuclear antibody">Anti-nuclear antibody</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Primary_biliary_cirrhosis" title="Primary biliary cirrhosis">PBC</a>:</i>
<ul>
<li><a href="/wiki/Anti-glycoprotein-210_antibodies" title="Anti-glycoprotein-210 antibodies">Anti-gp210</a></li>
<li><a href="/wiki/Anti-p62_antibodies" title="Anti-p62 antibodies">Anti-p62</a></li>
<li><a href="/wiki/Anti-sp100_antibodies" title="Anti-sp100 antibodies">Anti-sp100</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Extractable_nuclear_antigens" title="Extractable nuclear antigens">ENA</a>:</i>
<ul>
<li><a href="/wiki/Anti-topoisomerase_antibodies" title="Anti-topoisomerase antibodies">Anti-topoisomerase/Scl-70</a></li>
<li><a href="/wiki/Anti-Jo1" title="Anti-Jo1" class="mw-redirect">Anti-Jo1</a></li>
<li><a href="/wiki/Extractable_nuclear_antigens#ENA_4" title="Extractable nuclear antigens">ENA4</a>
<ul>
<li><a href="/wiki/LSm" title="LSm">Anti-Sm</a></li>
<li><a href="/wiki/Anti-nRNP" title="Anti-nRNP">Anti-nRNP</a></li>
<li><a href="/wiki/Anti-SSA/Ro_autoantibodies" title="Anti-SSA/Ro autoantibodies">Anti-Ro</a></li>
<li><a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Anti-La</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Anti-centromere_antibodies" title="Anti-centromere antibodies">Anti-centromere</a></li>
</ul>
<ul>
<li><a href="/wiki/Anti-dsDNA" title="Anti-dsDNA" class="mw-redirect">Anti-dsDNA</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Anti-mitochondrial_antibody" title="Anti-mitochondrial antibody">Anti-mitochondrial antibody</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Anti-cardiolipin_antibodies" title="Anti-cardiolipin antibodies">Anti-cardiolipin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Anti-<a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a> antibody</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Anti-neutrophil_cytoplasmic_antibody" title="Anti-neutrophil cytoplasmic antibody">Anti-neutrophil cytoplasmic</a>
<ul>
<li><a href="/wiki/C-ANCA" title="C-ANCA">C-ANCA</a></li>
<li><a href="/wiki/P-ANCA" title="P-ANCA">P-ANCA</a></li>
</ul>
</li>
<li><a href="/wiki/Anti-smooth_muscle_antibody" title="Anti-smooth muscle antibody">Anti-smooth muscle</a>
<ul>
<li><a href="/wiki/Anti-actin_antibodies" title="Anti-actin antibodies">Anti-actin</a></li>
</ul>
</li>
<li><a href="/wiki/Anti-thyroid_peroxidase_antibody" title="Anti-thyroid peroxidase antibody" class="mw-redirect">Anti-TPO/Antimicrosomal</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Cell membrane</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Anti-ganglioside_antibodies" title="Anti-ganglioside antibodies" class="mw-redirect">Anti-ganglioside</a></li>
<li><a href="/wiki/Anti-glomerular_basement_membrane_antibody" title="Anti-glomerular basement membrane antibody">Anti-GBM</a></li>
<li><a href="/wiki/Anti-glutamate_receptor_antibodies" title="Anti-glutamate receptor antibodies">Anti-glutamate</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Extracellular</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Anti-thrombin_antibodies" title="Anti-thrombin antibodies">Anti-thrombin</a></li>
<li><a href="/wiki/Lupus_anticoagulant" title="Lupus anticoagulant">Lupus anticoagulant</a></li>
</ul>
<ul>
<li><a href="/wiki/Gluten_sensitivity" title="Gluten sensitivity" class="mw-redirect">Gluten sensitivity</a>:
<ul>
<li><a href="/wiki/Anti-transglutaminase_antibodies" title="Anti-transglutaminase antibodies">Anti-transglutaminase</a>
<ul>
<li><a href="/wiki/Anti-gliadin_antibodies" title="Anti-gliadin antibodies">Anti-gliadin</a> not autoantibody</li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">RA</a></i>
<ul>
<li><a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">Rheumatoid factor/anti-IgG</a></li>
<li><a href="/wiki/Anti-citrullinated_protein_antibody" title="Anti-citrullinated protein antibody" class="mw-redirect">Anti-citrullinated peptide</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Multiple locations</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Anti-phospholipid</strong></li>
<li><a href="/wiki/Anti-apolipoprotein_antibodies" title="Anti-apolipoprotein antibodies">Anti-apolipoprotein</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymph_immune_and_complement_navs" title="Template:Lymph immune and complement navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymph_immune_and_complement_navs" title="Template talk:Lymph immune and complement navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymph_immune_and_complement_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Immune_system" title="Immune system">immune system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Lymphocytic_immune_system" title="Template:Lymphocytic immune system">Physiology</a>
<ul>
<li><a href="/wiki/Template:Lymphocytes" title="Template:Lymphocytes">cells</a></li>
<li><a href="/wiki/Template:Autoantigens" title="Template:Autoantigens">autoantigens</a></li>
<li><a href="/wiki/Template:Autoantibodies" title="Template:Autoantibodies">autoantibodies</a></li>
<li><a href="/wiki/Template:Complement_system" title="Template:Complement system">complement</a></li>
<li><a href="/wiki/Template:Surface_antigens" title="Template:Surface antigens">surface antigens</a></li>
<li><a href="/wiki/Template:Immunoglobulin_superfamily_immune_receptors" title="Template:Immunoglobulin superfamily immune receptors">IG receptors</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Allergic_conditions" title="Template:Allergic conditions">Allergies</a></li>
<li><a href="/wiki/Template:Lymphoid_and_complement_immunodeficiency" title="Template:Lymphoid and complement immunodeficiency">Immunodeficiency</a></li>
<li><a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">Immunoproliferative immunoglobulin disorders</a></li>
<li><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases">Hypersensitivity and autoimmune disorders</a></li>
<li><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy">Neoplasms and cancer</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Immunologic_techniques_and_tests" title="Template:Immunologic techniques and tests">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antihistamines" title="Template:Antihistamines">antihistamines</a></li>
<li><a href="/wiki/Template:Immunostimulants" title="Template:Immunostimulants">immunostimulants</a></li>
<li><a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants">immunosuppressants</a></li>
<li><a href="/wiki/Template:Monoclonals_for_immune_system" title="Template:Monoclonals for immune system">monoclonal antibodies</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Diseases_of_RBCs_and_megakaryocytes" title="Template:Diseases of RBCs and megakaryocytes"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Diseases_of_RBCs_and_megakaryocytes" title="Template talk:Diseases of RBCs and megakaryocytes"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Diseases_of_RBCs_and_megakaryocytes&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Hematologic_disease" title="Hematologic disease">Diseases</a> of <a href="/wiki/Red_blood_cell" title="Red blood cell">RBCs</a> and <a href="/wiki/Megakaryocyte" title="Megakaryocyte">megakaryocytes</a> / <a href="/wiki/Megakaryocyte%E2%80%93erythroid_progenitor_cell" title="Megakaryocyte–erythroid progenitor cell">MEP</a> (<a href="/wiki/ICD-10_Chapter_III:_Diseases_of_the_blood_and_blood-forming_organs,_and_certain_disorders_involving_the_immune_mechanism#D50-D89_-_Diseases_of_the_blood_and_blood-forming_organs_and_certain_disorders_involving_the_immune_mechanism" title="ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism">D50–69,74</a>, <a href="/wiki/List_of_ICD-9_codes_280%E2%80%93289:_diseases_of_the_blood_and_blood-forming_organs" title="List of ICD-9 codes 280–289: diseases of the blood and blood-forming organs">280–287</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Red_blood_cell" title="Red blood cell">Red<br />
blood cells</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">↑</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Polycythemia" title="Polycythemia">Polycythemia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Polycythemia_vera" title="Polycythemia vera">Polycythemia vera</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">↓</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Anemia" title="Anemia">Anemia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Nutritional_anemia" title="Nutritional anemia">Nutritional</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Microcytic_anemia" title="Microcytic anemia">Micro-</a>: <a href="/wiki/Iron-deficiency_anemia" title="Iron-deficiency anemia">Iron-deficiency anemia</a>
<ul>
<li><a href="/wiki/Plummer%E2%80%93Vinson_syndrome" title="Plummer–Vinson syndrome">Plummer–Vinson syndrome</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Macrocytic_anemia" title="Macrocytic anemia">Macro-</a>: <a href="/wiki/Megaloblastic_anemia" title="Megaloblastic anemia">Megaloblastic anemia</a>
<ul>
<li><a href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hemolytic_anemia" title="Hemolytic anemia">Hemolytic</a><br />
(mostly <a href="/wiki/Normocytic_anemia" title="Normocytic anemia">normo-</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Congenital_hemolytic_anemia" title="Congenital hemolytic anemia">Hereditary</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Enzymopathy" title="Enzymopathy" class="mw-redirect">enzymopathy</a>:</i> <a href="/wiki/Glucose-6-phosphate_dehydrogenase_deficiency" title="Glucose-6-phosphate dehydrogenase deficiency">G6PD</a></li>
<li><i><a href="/wiki/Glycolysis" title="Glycolysis">glycolysis</a></i>
<ul>
<li><a href="/wiki/Pyruvate_kinase_deficiency" title="Pyruvate kinase deficiency">PK</a></li>
<li><a href="/wiki/Triosephosphate_isomerase_deficiency" title="Triosephosphate isomerase deficiency">TI</a></li>
<li><a href="/wiki/Hexokinase_deficiency" title="Hexokinase deficiency">HK</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Hemoglobinopathy" title="Hemoglobinopathy">hemoglobinopathy</a>:</i> <a href="/wiki/Thalassemia" title="Thalassemia">Thalassemia</a>
<ul>
<li><a href="/wiki/Alpha-thalassemia" title="Alpha-thalassemia">alpha</a></li>
<li><a href="/wiki/Beta-thalassemia" title="Beta-thalassemia" class="mw-redirect">beta</a></li>
<li><a href="/wiki/Delta-thalassemia" title="Delta-thalassemia">delta</a></li>
</ul>
</li>
<li><a href="/wiki/Sickle-cell_disease" title="Sickle-cell disease">Sickle-cell disease</a>/<a href="/wiki/Sickle_cell_trait" title="Sickle cell trait">trait</a></li>
<li><a href="/wiki/Hereditary_persistence_of_fetal_hemoglobin" title="Hereditary persistence of fetal hemoglobin">HPFH</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Red_blood_cell#Membranes_and_surface_proteins" title="Red blood cell">membrane</a>:</i> <a href="/wiki/Hereditary_spherocytosis" title="Hereditary spherocytosis">Hereditary spherocytosis</a>
<ul>
<li><a href="/wiki/Minkowski%E2%80%93Chauffard_syndrome" title="Minkowski–Chauffard syndrome" class="mw-redirect">Minkowski–Chauffard syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Hereditary_elliptocytosis" title="Hereditary elliptocytosis">Hereditary elliptocytosis</a>
<ul>
<li><a href="/wiki/Southeast_Asian_ovalocytosis" title="Southeast Asian ovalocytosis">Southeast Asian ovalocytosis</a></li>
</ul>
</li>
<li><a href="/wiki/Hereditary_stomatocytosis" title="Hereditary stomatocytosis">Hereditary stomatocytosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Acquired_hemolytic_anemia" title="Acquired hemolytic anemia">Acquired</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune</a>
<ul>
<li><a href="/wiki/Warm_autoimmune_hemolytic_anemia" title="Warm autoimmune hemolytic anemia">WAHA</a></li>
<li><a href="/wiki/Cold_agglutinin_disease" title="Cold agglutinin disease">CAD</a></li>
<li><a href="/wiki/Paroxysmal_cold_hemoglobinuria" title="Paroxysmal cold hemoglobinuria">PCH</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Red_blood_cell#Membranes_and_surface_proteins" title="Red blood cell">membrane</a></i>
<ul>
<li><a href="/wiki/Paroxysmal_nocturnal_hemoglobinuria" title="Paroxysmal nocturnal hemoglobinuria">PNH</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Microangiopathic_hemolytic_anemia" title="Microangiopathic hemolytic anemia">MAHA</a></li>
<li><a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">TM</a>
<ul>
<li><a href="/wiki/Hemolytic-uremic_syndrome" title="Hemolytic-uremic syndrome">HUS</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Drug-induced_autoimmune_hemolytic_anemia" title="Drug-induced autoimmune hemolytic anemia">Drug-induced autoimmune</a></li>
<li><a href="/wiki/Drug-induced_nonautoimmune_hemolytic_anemia" title="Drug-induced nonautoimmune hemolytic anemia">Drug-induced nonautoimmune</a></li>
</ul>
<ul>
<li><a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Aplastic_anemia" title="Aplastic anemia">Aplastic</a><br />
(mostly <a href="/wiki/Normocytic_anemia" title="Normocytic anemia">normo-</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Congenital_hypoplastic_anemia" title="Congenital hypoplastic anemia">Hereditary</a>: <a href="/wiki/Fanconi_anemia" title="Fanconi anemia">Fanconi anemia</a></li>
<li><a href="/wiki/Diamond%E2%80%93Blackfan_anemia" title="Diamond–Blackfan anemia">Diamond–Blackfan anemia</a></li>
</ul>
<ul>
<li>Acquired: <a href="/wiki/Pure_red_cell_aplasia" title="Pure red cell aplasia">PRCA</a></li>
<li><a href="/wiki/Sideroblastic_anemia" title="Sideroblastic anemia">Sideroblastic anemia</a></li>
<li><a href="/wiki/Myelophthisic_anemia" title="Myelophthisic anemia">Myelophthisic</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Red_blood_cell_indices" title="Red blood cell indices">Blood tests</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Mean_corpuscular_volume" title="Mean corpuscular volume">MCV</a></i>
<ul>
<li><a href="/wiki/Normocytic_anemia" title="Normocytic anemia">Normocytic</a></li>
<li><a href="/wiki/Microcytic_anemia" title="Microcytic anemia">Microcytic</a></li>
<li><a href="/wiki/Macrocytic_anemia" title="Macrocytic anemia">Macrocytic</a></li>
</ul>
</li>
<li><i><a href="/wiki/Mean_corpuscular_hemoglobin_concentration" title="Mean corpuscular hemoglobin concentration">MCHC</a></i>
<ul>
<li><a href="/wiki/Normochromic_anemia" title="Normochromic anemia">Normochromic</a></li>
<li><a href="/wiki/Hypochromic_anemia" title="Hypochromic anemia">Hypochromic</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Methemoglobinemia" title="Methemoglobinemia">Methemoglobinemia</a></li>
<li><a href="/wiki/Sulfhemoglobinemia" title="Sulfhemoglobinemia">Sulfhemoglobinemia</a></li>
<li><a href="/wiki/Reticulocytopenia" title="Reticulocytopenia">Reticulocytopenia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Coagulation" title="Coagulation">Coagulation</a>/<br />
<a href="/wiki/Coagulopathy" title="Coagulopathy">coagulopathy</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">↑</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Thrombophilia" title="Thrombophilia">Hyper-<br />
coagulability</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>primary:</i> <a href="/wiki/Antithrombin_III_deficiency" title="Antithrombin III deficiency">Antithrombin III deficiency</a></li>
<li><a href="/wiki/Protein_C_deficiency" title="Protein C deficiency">Protein C deficiency</a>/<a href="/wiki/Activated_protein_C_resistance" title="Activated protein C resistance">Activated protein C resistance</a>/<a href="/wiki/Protein_S_deficiency" title="Protein S deficiency">Protein S deficiency</a>/<a href="/wiki/Factor_V_Leiden" title="Factor V Leiden">Factor V Leiden</a></li>
<li><a href="/wiki/Prothrombin_G20210A" title="Prothrombin G20210A">Prothrombin G20210A</a></li>
<li><a href="/wiki/Sticky_platelet_syndrome" title="Sticky platelet syndrome">Sticky platelet syndrome</a></li>
</ul>
<ul>
<li><i>acquired:</i><a href="/wiki/Thrombocytosis" title="Thrombocytosis">Thrombocytosis</a>
<ul>
<li><a href="/wiki/Essential_thrombocythaemia" title="Essential thrombocythaemia">essential</a></li>
</ul>
</li>
<li><a href="/wiki/Disseminated_intravascular_coagulation" title="Disseminated intravascular coagulation">DIC</a>
<ul>
<li><a href="/wiki/Congenital_afibrinogenemia" title="Congenital afibrinogenemia">Congenital afibrinogenemia</a></li>
<li><a href="/wiki/Purpura_fulminans" title="Purpura fulminans">Purpura fulminans</a></li>
</ul>
</li>
<li><i><a href="/wiki/Autoimmune" title="Autoimmune" class="mw-redirect">autoimmune</a></i>
<ul>
<li><strong class="selflink">Antiphospholipid</strong></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">↓</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Bleeding_diathesis" title="Bleeding diathesis">Hypo-<br />
coagulability</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">Thrombocytopenia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Thrombocytopenic_purpura" title="Thrombocytopenic purpura">Thrombocytopenic purpura</a>: <a href="/wiki/Idiopathic_thrombocytopenic_purpura" title="Idiopathic thrombocytopenic purpura">ITP</a>
<ul>
<li><a href="/wiki/Evans_syndrome" title="Evans syndrome">Evans syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">TM</a>
<ul>
<li><a href="/wiki/Thrombotic_thrombocytopenic_purpura" title="Thrombotic thrombocytopenic purpura">TTP</a></li>
<li><a href="/wiki/Upshaw_Schulman_syndrome" title="Upshaw Schulman syndrome" class="mw-redirect">Upshaw Schulman syndrome</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Heparin-induced_thrombocytopenia" title="Heparin-induced thrombocytopenia">Heparin-induced thrombocytopenia</a></li>
<li><a href="/wiki/May%E2%80%93Hegglin_anomaly" title="May–Hegglin anomaly">May–Hegglin anomaly</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Platelet#Diseases" title="Platelet">Platelet function</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>adhesion</i>
<ul>
<li><a href="/wiki/Bernard%E2%80%93Soulier_syndrome" title="Bernard–Soulier syndrome">Bernard–Soulier syndrome</a></li>
</ul>
</li>
<li><i>aggregation</i>
<ul>
<li><a href="/wiki/Glanzmann%27s_thrombasthenia" title="Glanzmann's thrombasthenia">Glanzmann's thrombasthenia</a></li>
</ul>
</li>
<li><i><a href="/wiki/Platelet_storage_pool_deficiency" title="Platelet storage pool deficiency">platelet storage pool deficiency</a></i>
<ul>
<li><a href="/wiki/Hermansky%E2%80%93Pudlak_syndrome" title="Hermansky–Pudlak syndrome">Hermansky–Pudlak syndrome</a></li>
<li><a href="/wiki/Gray_platelet_syndrome" title="Gray platelet syndrome">Gray platelet syndrome</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Clotting_factor" title="Clotting factor" class="mw-redirect">Clotting factor</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Haemophilia" title="Haemophilia">Hemophilia</a>
<ul>
<li><a href="/wiki/Haemophilia_A" title="Haemophilia A">A/VIII</a></li>
<li><a href="/wiki/Haemophilia_B" title="Haemophilia B">B/IX</a></li>
<li><a href="/wiki/Haemophilia_C" title="Haemophilia C">C/XI</a></li>
</ul>
</li>
<li><a href="/wiki/Von_Willebrand_disease" title="Von Willebrand disease">von Willebrand disease</a></li>
<li><a href="/wiki/Hypoprothrombinemia" title="Hypoprothrombinemia">Hypoprothrombinemia/II</a></li>
<li><a href="/wiki/Factor_XIII_deficiency" title="Factor XIII deficiency">XIII</a></li>
<li><a href="/wiki/Dysfibrinogenemia" title="Dysfibrinogenemia">Dysfibrinogenemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Myeloid_navs" title="Template:Myeloid navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Myeloid_navs" title="Template talk:Myeloid navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Myeloid_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Myeloid" title="Myeloid">cells from bone marrow</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Myeloid_innate_immune_system" title="Template:Myeloid innate immune system">Immune system</a></li>
<li><a href="/wiki/Template:Myeloid_blood_cells_and_plasma" title="Template:Myeloid blood cells and plasma">Cells</a></li>
<li><a href="/wiki/Template:Myeloid_physiology" title="Template:Myeloid physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Coagulation" title="Template:Coagulation">coagulation</a></li>
<li><a href="/wiki/Template:Hemeproteins" title="Template:Hemeproteins">proteins</a></li>
<li><a href="/wiki/Template:Granule_contents" title="Template:Granule contents">granule contents</a></li>
<li><a href="/wiki/Template:Colony-stimulating_factors" title="Template:Colony-stimulating factors">colony-stimulating</a></li>
<li>heme and porphyrin
<ul>
<li><i><a href="/wiki/Template:Porphyrin_metabolism_enzymes" title="Template:Porphyrin metabolism enzymes">metabolism</a></i></li>
<li><i><a href="/wiki/Template:Heme_metabolism_intermediates" title="Template:Heme metabolism intermediates">intermediates</a></i></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Diseases_of_RBCs_and_megakaryocytes" title="Template:Diseases of RBCs and megakaryocytes">Red blood cell</a></li>
<li><a href="/wiki/Template:Monocyte_and_granulocyte_disease" title="Template:Monocyte and granulocyte disease">Monocyte and granulocyte</a></li>
<li><a href="/wiki/Template:Myeloid_malignancy" title="Template:Myeloid malignancy">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Histiocytosis" title="Template:Histiocytosis">Histiocytosis</a></li>
<li><a href="/wiki/Template:Cardiovascular_system_symptoms_and_signs" title="Template:Cardiovascular system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_hematology" title="Template:Eponymous medical signs for hematology">eponymous</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Myeloid_blood_tests" title="Template:Myeloid blood tests">Blood tests</a>
<ul>
<li><a href="/wiki/Template:Abnormal_clinical_and_laboratory_findings_for_blood" title="Template:Abnormal clinical and laboratory findings for blood">findings</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Transfusion_medicine" title="Template:Transfusion medicine">Transfusion</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antithrombotics" title="Template:Antithrombotics">thrombosis</a></li>
<li><a href="/wiki/Template:Antihemorrhagics" title="Template:Antihemorrhagics">bleeding</a></li>
<li><a href="/wiki/Template:B03,_B05,_B06" title="Template:B03, B05, B06">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1193
CPU time usage: 0.499 seconds
Real time usage: 0.581 seconds
Preprocessor visited node count: 2281/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 177096/2097152 bytes
Template argument size: 1944/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 2/500
Lua time usage: 0.165/10.000 seconds
Lua memory usage: 3.71 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  398.719      1 - -total
 41.74%  166.408     13 - Template:Navbox
 29.36%  117.059      1 - Template:Reflist
 27.17%  108.320      1 - Template:Infobox_disease
 24.41%   97.314      1 - Template:Infobox
 14.30%   57.007      1 - Template:Hematology
 13.02%   51.927     14 - Template:Cite_journal
 12.58%   50.178      3 - Template:Citation_needed
 10.19%   40.638      3 - Template:Fix
  8.97%   35.754      6 - Template:Category_handler
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:238273-0!*!0!!en!4!* and timestamp 20150711184408 and revision id 670102164
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Antiphospholipid_syndrome&amp;oldid=670102164">https://en.wikipedia.org/w/index.php?title=Antiphospholipid_syndrome&amp;oldid=670102164</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Coagulopathies" title="Category:Coagulopathies">Coagulopathies</a></li><li><a href="/wiki/Category:Rheumatology" title="Category:Rheumatology">Rheumatology</a></li><li><a href="/wiki/Category:Autoimmune_diseases" title="Category:Autoimmune diseases">Autoimmune diseases</a></li><li><a href="/wiki/Category:Neurological_disorders" title="Category:Neurological disorders">Neurological disorders</a></li><li><a href="/wiki/Category:Obstetrics" title="Category:Obstetrics">Obstetrics</a></li><li><a href="/wiki/Category:Syndromes" title="Category:Syndromes">Syndromes</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2011" title="Category:Articles with unsourced statements from October 2011">Articles with unsourced statements from October 2011</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_January_2008" title="Category:Articles with unsourced statements from January 2008">Articles with unsourced statements from January 2008</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Antiphospholipid+syndrome&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Antiphospholipid+syndrome" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Antiphospholipid_syndrome"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Antiphospholipid_syndrome"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Antiphospholipid_syndrome" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Antiphospholipid_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Antiphospholipid_syndrome" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;oldid=670102164" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q582207" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Antiphospholipid_syndrome&amp;id=670102164" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Antiphospholipid+syndrome">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Antiphospholipid+syndrome&amp;oldid=670102164&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Antiphospholipid_syndrome&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%A3%D8%B6%D8%AF%D8%A7%D8%AF_%D8%A7%D9%84%D9%81%D9%88%D8%B3%D9%81%D9%88%D9%84%D9%8A%D8%A8%D9%8A%D8%AF" title="متلازمة أضداد الفوسفوليبيد – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Antiphospholipid-Syndrom" title="Antiphospholipid-Syndrom – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Anticuerpos_antifosfol%C3%ADpidos" title="Anticuerpos antifosfolípidos – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Syndrome_des_antiphospholipides" title="Syndrome des antiphospholipides – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Sindrom_antibodi_antifosfolipid" title="Sindrom antibodi antifosfolipid – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Sindrome_da_anticorpi_antifosfolipidi" title="Sindrome da anticorpi antifosfolipidi – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%AA%D7%A1%D7%9E%D7%95%D7%A0%D7%AA_%D7%90%D7%A0%D7%98%D7%99-%D7%A4%D7%95%D7%A1%D7%A4%D7%95%D7%9C%D7%99%D7%A4%D7%99%D7%93%D7%99%D7%AA" title="תסמונת אנטי-פוספוליפידית – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-lv"><a href="//lv.wikipedia.org/wiki/Antifosfolip%C4%ABdu_sindroms" title="Antifosfolipīdu sindroms – Latvian" lang="lv" hreflang="lv">Latviešu</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/Antifosfolipidinis_sindromas" title="Antifosfolipidinis sindromas – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Antifosfolipidesyndroom" title="Antifosfolipidesyndroom – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E6%8A%97%E3%83%AA%E3%83%B3%E8%84%82%E8%B3%AA%E6%8A%97%E4%BD%93%E7%97%87%E5%80%99%E7%BE%A4" title="抗リン脂質抗体症候群 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_antyfosfolipidowy" title="Zespół antyfosfolipidowy – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/S%C3%ADndrome_do_anticorpo_antifosfolip%C3%ADdeo" title="Síndrome do anticorpo antifosfolipídeo – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D1%84%D0%BE%D1%81%D1%84%D0%BE%D0%BB%D0%B8%D0%BF%D0%B8%D0%B4%D0%BD%D0%B8_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC" title="Антифосфолипидни синдром – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Antifosfolipidsyndrom" title="Antifosfolipidsyndrom – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%81%E0%B8%A5%E0%B8%B8%E0%B9%88%E0%B8%A1%E0%B8%AD%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%81%E0%B8%AD%E0%B8%99%E0%B9%84%E0%B8%97%E0%B8%9F%E0%B8%AD%E0%B8%AA%E0%B9%82%E0%B8%9F%E0%B9%84%E0%B8%A5%E0%B8%9B%E0%B8%B4%E0%B8%94" title="กลุ่มอาการแอนไทฟอสโฟไลปิด – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E6%8A%97%E7%A3%B7%E8%84%82%E7%BB%BC%E5%90%88%E5%BE%81" title="抗磷脂综合征 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q582207#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 5 July 2015, at 21:20.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Antiphospholipid_syndrome&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":111,"wgHostname":"mw1042"});
}</script>
	</body>
</html>
